| Patient | Targeted drugs (daily dose/duration) | ||||||||||
| PB | Pazopanib | Everolimus | Sirolimus | Dasatinib | Vorinostat | Erlotinib | Sorafenib | Lapatinib | Bevacizumab | Response (date) | |
| 1 | 12 g/9 w | 200 mg/1 w 400 mg/6 w | 10 mg/ 3 w |
|
| 200 mg/3 w 300 mg/ 8.5 w | 150 mg/ 3 w |
|
| 2.5 mg/kg × 1 5 mg/kg × 4 | PR Nov 30, 2010 |
| 2 | 3 g/2 w 6 g/6 w 9 g/6 w 12 g/12 w | 200 mg/9 w |
| 1 mg/ 14 w 3 mg/ 2.5 w | 50 mg/ 13 w |
| 100 mg/ 12.5 w |
|
|
| SD May 17, 2012 |
| 4 | 12 g/ 7.3 w | 200 mg/ 5.5 w | 5 mg/ 6 w |
| 50 mg/ 1 w |
| 100 mg/ 5 w |
|
| 10 mg/kg × 3 | CR Apr 8, 2013 |
| 5 | 18 g/ 6 w | 200 mg/1 w 400 mg/5 w | 10 mg/ 6 w |
|
|
|
|
| 750 mg/ 5.5 w | 5 mg/kg × 1 10 mg/kg × 1 | PR Jul 11, 2013 |
| 6 | 12 g/ 16 w | 200 mg/ 15 w | 10 mg/ 15.5 w |
|
|
| 100 mg/6 w 150 mg/9.5 w |
|
|
| SD Feb 19, 2014 |
| 8 | 18 g/ 12 w | 200 mg/ 6 w | 5 mg/ 3 w |
| 50 mg/ 7 w |
|
|
|
| 10 mg/kg × 4 | SD Sep 3, 2014 |
| 9 | 10 g/ 10 w | 200 mg/ 3.5w | 5 mg/ 9.5 w |
| 50 mg/ 9.5 w |
|
| 200 mg/ 5.5 w |
| 8 mg/kg × 3 | PR Aug 28, 2014 |
| 10 | 12 g/ 5.5 w | 200 mg/ 5 w | 5 mg/ 5.5 w |
| 50 mg/ 4.5 w |
|
|
|
| 10 mg/kg × 3 | CR Sep 4, 2014 |
| 11 | 12 g/ 4 w | 200 mg/ 4 w | 5 mg/ 4 w |
| 50 mg/ 3.5 w |
|
|
|
| 10 mg/kg × 3 | PR Sep 16, 2014 |